In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million)
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...